Bladder Volume Manometer Catheter Market Outlook:
Bladder Volume Manometer Catheter Market size was over USD 580.4 million in 2024 and is estimated to reach USD 1.3 billion by the end of 2034, expanding at a CAGR of 6.4% during the forecast timeline, i.e., 2025-2034. In 2025, the industry size of bladder volume manometer catheter is estimated at USD 615.6 million.
The rising prevalence of urinary retention, neurogenic bladder, and post-operative voiding dysfunction is fueling the market. According to the American Urological Association, indwelling catheters are widely used for acute and chronic urinary retention. The growing demand for precise bladder pressure monitoring across both inpatient and outpatient settings is also creating a surge in this sector. Additionally, urological disorders are evidently observed among older citizens. Hence, the worldwide aging population is steadily enlarging the patient pool requiring these specialized surgical solutions.
The bladder volume manometer catheter market faces moderate inflationary pressures, which are reflected in the changes in key economic indicators. For instance, the substantial rise in the producer price index (PPI) for medical devices highlights upstream manufacturing costs. Subsequently, a continuous increase in the consumer price index (CPI) for medical goods, including catheters, underscores reimbursement dynamics and payer negotiations. These indices foster a need for a balanced business model, combining crucial assets of cost-optimized production and insurer coverage expansion, ensuring sustainable access to these critical urological devices.

Bladder Volume Manometer Catheter Market - Growth Drivers and Challenges
Growth Drivers
- Clinical advantages of early intervention: With validation gained from several certification authorities about the efficacy in cost saving and treatment, the market is gaining traction. The supportive studies demonstrate that these devices play a crucial role in reducing catheter-associated urinary tract infections (CAUTIs) by enabling early detection of urinary retention and preventing unnecessary catheterizations. Thus, following a 2022 AHRQ implementation guide, U.S. hospitals incorporated bladder monitoring technologies into their mainstream urology practice, driving adoption in this sector.
- Increasing personal and public spending: Favorable reimbursement policies and substantial healthcare expenditures are accelerating adoption in the bladder volume manometer catheter market. For instance, Medicare Part B covers 80.4% of urinary catheter costs, reducing patient financial barriers in this sector. As a result, in 2020 alone, spending on urinary catheters surpassed $407.2 million. Additionally, FDA support for urinary incontinence device trials fosters innovation in bladder pressure monitoring technologies, escalating the sector's reach. These financial and regulatory tailwinds create a stable foundation for this field through streamlining technological advancement.
Historical Patient Growth (2010-2020) and Its Impact on the Market
Bladder Volume Manometer Catheter Users
Country |
2010 Patients (Millions) |
2020 Patients (Millions) |
Growth (2010-2020) |
U.S. |
1.3 |
2.2 |
75.2% |
Germany |
0.66 |
1.2 |
69.3% |
France |
0.59 |
0.96 |
64.5% |
Spain |
0.43 |
0.79 |
86.4% |
Australia |
0.32 |
0.56 |
77.4% |
Japan |
0.89 |
1.6 |
70.1% |
India |
0.26 |
0.93 |
268.3% |
China |
0.49 |
1.7 |
233.5% |
Feasibility Models for Bladder Volume Manometer Catheter Market Expansion
Feasibility Business Models (2022-2024)
Country |
Expansion Model Description |
Revenue Growth |
India |
Local partnerships under “Make in India” + PLI scheme |
12.1% |
U.S. |
Medicare reimbursement expansion for diagnostic catheters |
9.5% |
Germany |
EU digital health integration for outpatient bladder monitoring |
7.9% |
France |
Public-private R&D consortia for sensor-based catheter innovation |
6.6% |
Japan |
Hospital-based procurement incentives for advanced urodynamic devices |
6.0% |
Australia |
Remote care reimbursement for bladder pressure monitoring in aged care |
4.8% |
China |
Export-driven assembly model with government-backed infrastructure grants |
10.3% |
Challenges
- Government-imposed pricing constraints: Despite the gradual increase in accessibility, the price controls implemented by individual governing bodies often limit profitability from premium pricing products in the bladder volume manometer catheter market. For instance, the 2020 pricing policy guidelines, released by the World Health Organization (WHO), pushed several countries to enforce strict price caps on diagnostic devices. This further squeezed supplier profitability in those marketplaces. However, to mitigate this issue, the suppliers in Europe formed strategic collaborations.
- Fragmented procurement systems: In low- and middle-income countries (LMICs), sufficient availability still imposes a notable hurdle in the market. According to the Global Atlas of Medical Devices report, published by the WHO in 2022, the lack of centralized procurement across these nations often complicates the pathway of participation in public tenders for suppliers. This restricts efficient distribution and hence creates operational challenges for manufacturers in such emerging economies.
Bladder Volume Manometer Catheter Market Size and Forecast:
Report Attribute | Details |
---|---|
Base Year |
2024 |
Forecast Year |
2025-2034 |
CAGR |
6.4% |
Base Year Market Size (2024) |
USD 580.4 million |
Forecast Year Market Size (2034) |
USD 1.3 billion |
Regional Scope |
|
Bladder Volume Manometer Catheter Market Segmentation:
End user Segment Analysis
In terms of end users, the hospitals segment is expected to dominate the bladder volume manometer catheter market with a revenue share of 29.6% over the assessed period. The central role of these organizations in availing surgical procedures and post-operative monitoring is the major driver behind this leadership. According to the WHO, healthcare facilities across high- and middle-income countries are increasingly investing in urodynamic diagnostics to address aging populations' needs. Furthermore, government investments for infrastructural upgrades and digital health integration also reinforce the segment's position as the primary adoption channel for these advanced urological solutions.
Type Segment Analysis
Based on type, the disposable bladder volume manometer catheters segment is poised to represent a significant share of 34.3% in the bladder volume manometer catheter market by the end of 2034. The tightening of infection control requirements is forcing maximum clinical settings to adopt one-time-use surgical instruments. In support of this, the CDC reported that these single-use devices help address 75.3% of hospital-acquired urinary tract infections (UTIs). Moreover, rapid modernization of healthcare facilities across various regions is making disposable variants the gold standard for CMS reimbursement criteria and compliance with evolving infection prevention standards.
Our in-depth analysis of the global market includes the following segments:
Segment |
Subsegment |
End user |
|
Type |
|
Application |
|

Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Bladder Volume Manometer Catheter Market - Regional Analysis
North America Market Insights
North America is predicted to capture the largest share of 38.7% in the global bladder volume manometer catheter market throughout the discussed tenure. This leadership is a result of the region's aging population, high urinary disorder prevalence, and favorable reimbursement policies. For instance, the notable expansion of reimbursement coverage for urological diagnostics by Medicare & Medicaid service providers escalated adoption and cash inflow in this category. Moreover, the region's robust diagnostic infrastructure and continuous R&D funding are streamlining the management of associated urological interventions. This is making North America the epicenter of an advanced and favorable healthcare ecosystem.
The U.S. is augmenting dominance over the regional market on account of strong payer support and clinical demand for precision urological diagnostics. As evidence, CMS data shows that the Medicare expenditure on incontinence devices grew by 15.3% from 2020 to 2024 and accounted for $800.2 million. Additionally, in 2024, Medicaid expanded its coverage to 10.5% more patients with a $1.3 billion allocation. Federal agencies are also actively promoting urinary retention management and catheter innovation, which is backed by PhRMA/BIO advocacy and robust R&D investment.
The Canada market is also expanding through targeted public health investments. In this regard, in 2023 alone, Health Canada dedicated approximately $3.3 billion to bladder diagnostics, reflecting a 12.5% increase from 2020. Besides, the governing bodies of Ontario and British Columbia also boosted their spending by 18.4% from 2021 to 2024 to address bladder dysfunction, as reported by the Canadian Institute for Health Information (CIHI). Moreover, federal procurement incentives and advocacy by BioteCanada are cultivating a strong domestic R&D network to curate cutting-edge advances in this field.
APAC Market Insights
The Asia Pacific bladder volume manometer catheter market is anticipated to grow at the fastest pace by the end of 2034. Rapid aging and government-led healthcare modernization initiatives are the primary growth engines of this region. Key landscapes, including Japan, China, and India, are propelling adoption in this sector through continuous funding and strategic procurement. Besides, the regulatory reforms and increasing disposable income are collectively influencing this merchandise to expand its territory across these emerging economies. Furthermore, the combination of infection control needs and telehealth expansion is positioning APAC as the global growth hotspot.
China is augmenting the bladder volume manometer catheter market with a predominant captivity over the regional output. With government healthcare spending increasing 15.2% over five years and over 1.5 million patients diagnosed, the country is representing both the key producer and consumer base for this sector. The dramatic increase in the nationwide incidences of urological conditions is evidence of this surge, as per the National Medical Products Administration (NMPA). Furthermore, the streamlined device approvals by the NMPA also accelerated access to this field for both domestic and foreign manufacturers.
India is becoming a hub of localized production and development for the APAC bladder volume manometer catheter market. Notable expansion of the country's medical device industry, reaching $12.3 billion in 2023, is fueling the goal of attaining global recognition in this category. This cohort of strengthening domestic manufacturing capacity is further supported by the National Health Mission and the Department of Biotechnology in India, which increased funding for diagnostic tools. As a result, academic and state partnerships curated the development of more than 26 novel medical devices under the supervision of the Biomedical Engineering and Technology Innovation Centre (BETIC).
Country-wise Government Provinces
Country |
Government Initiative / Policy |
Budget / Funding |
Key Impact |
Japan |
AMED R&D Grants for Urodynamic Devices |
~$28.2 million annually (2021-2024) |
Accelerated development of AI-integrated catheters; 51+ hospital adoptions. |
Australia |
MBS (Medicare) Expansion for Urological Diagnostics |
$120.3 million (2023–2025) |
Improved reimbursement for bladder pressure monitoring in outpatient care. |
South Korea |
Digital Health Innovation Fund |
~$63.4 million (2022-2025) |
Supported telehealth-integrated catheters; 30.1% adoption growth in clinics. |
Malaysia |
MyMeditech Grant for Local Device Manufacturing |
~$32.1 million (2021-2025) |
Boosted domestic production; reduced import dependency by 15.2%. |
Europe Market Insights
The Europe bladder volume manometer catheter market is estimated to capture the 2nd largest revenue share during the timeline between 2025 and 2034. The geriatric demographics and advanced healthcare infrastructure are the pillars of the region's propagation in this sector. As evidence, the governing authorities of the region released the EU4Health Programme with an outlay of €2.6 billion to improve diagnostics and streamline MDR/IVDR regulations. This initiative was particularly focused on implementing such reforms in key landscapes, including Germany, France, and the UK. Moreover, the European Health Data Space is enabling data-driven care, which is bringing innovation in this market.
Germany dominates the Europe bladder volume manometer catheter market, with €4.2 billion allocation in 2024. The robust federal health funding and BÄK's clinical endorsements are cumulatively fueling the country's proprietorship in the region. The decentralized healthcare system in the nation also facilitates rapid adoption across public and private hospitals. Besides, the MDR compliance positions it as a gateway for global manufacturers, which is further coupled with favorable reimbursement policies and government subsidies.
The UK has significantly increased its focus on bladder diagnostics. The nation's government supported this cohort by allocating 8.3% of its healthcare budget in 2023, with an aim to meet growing demand in NHS hospitals. The National Health Service (NHS) is also integrating bladder volume manometer catheters into standard urology protocols, as per the pathway directed by the Association of the British Pharmaceutical Industry (ABPI). Moreover, the UK remains a key European market, projected to sustain long-term growth through 2034.
Government Funding & Policies
Country |
Policy/Initiative |
Funding (Million) |
Key Focus |
France |
Innovative Therapies Program (HAS Fast-Track) |
€120.2 (2023-2027) |
Accelerated approvals |
Spain |
AEMPS Regulatory Sandbox (Personalized Vaccines) |
€30.1 (2022-2026) |
Clinical trial support |
Italy |
AIFA Advanced Therapies Reimbursement Fund |
€55.1 (2024-2028) |
Patient access expansion |
Russia |
Skolkovo Innovation Center (Biotech Grants) |
~€8.2 (2025) |
mRNA-DC vaccine R&D |

Key Bladder Volume Manometer Catheter Market Players:
- Amecath
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- MEDICA
- UROMED
- Mednova Medical Technology
- Mediplus
- Urotech
- Hamilton Syringes & Needles
- Hi-Tech Medicare Devices
- Histo
- Medax
- Multi-G
- Coloplast
- Teleflex
- Cook Medical
- B. Braun Melsungen AG
- Romsons
- Bard (a BD company)
- Narang Medical Limited
The bladder volume manometer catheter market features moderate fragmentation, with multinational players like MEDICA, Coloplast, and Teleflex competing against cost-efficient solutions. Manufacturers in Asia are establishing their distinguished position through wireless and sensor-enabled innovations. They are also solidifying their commercial operations with accelerated regulatory compliance and strategic localization. Moreover, cost-optimized production and public-private partnerships are creating sustainable dynamics for this sector.
Such key players are:
Recent Developments
- In March 2024, Becton Dickinson (BD) launched its BD SensaTrak Bluetooth-Enabled Catheter, a next-generation bladder volume monitoring solution with integrated Bluetooth for real-time EHR data transmission. The product captured 8.3% of the urology monitoring segment within three months.
- In January 2024, Medtronic introduced its CareGuide Smart Catheter System, featuring FDA-approved manometer-based pressure sensing and AI analytics to predict urinary retention risks. It drove $120.4 million in incremental revenue for the company's urology division in the 1st quarter of 2024.
- Report ID: 7868
- Published Date: Jul 08, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert